Will wearing two masks better protect me from the virus? AP Illustration/Peter Hamlin
Does wearing two masks provide more protection?
It depends, but it’s possible that doubling up could help in some situations.
The U.S. Centers for Disease Control and Prevention recommends wearing a cloth mask made with two or more layers, and ensuring it covers your nose and mouth. The agency says it should fit snugly so there aren't any gaps at the sides of your face.
Wearing just one mask should be enough for most situations, as long as it fits well and isn't loose, said Dr. David Hamer, an infectious disease expert at Boston University.
“Starting out with a good mask to begin with is going to be key,” Hamer said.
Still, some people might want extra protection if they're at risk for severe illness if infected or will be in situations where they expect to be around others for extended periods, such as on a plane.
One option in scenarios when you want extra protection is to wear a cloth mask as well as a regular surgical mask, said Dr. Monica Gandhi, an infectious disease expert at the University of California, San Francisco.
Gandhi said that combination -- with either mask on top -- could help achieve a similar effect as the N95 mask. She recommended the added protection for people who will be indoors in areas where transmission rates are high — which could reflect the circulation of more contagious variants.
Another option Gandhi and a colleague recommend for situations where you want “maximum” protection: A two-layer cloth mask that has a filter material in between.
With single cloth masks for everyday use, Gandhi noted it's important that they're made of tightly-woven material and have at least two layers, which creates “an obstacle course” that makes it harder for virus-carrying particles to break through.
An FDA panel has recommended the low-dose Pfizer vaccine for kids ages five to 11. The recommendation now cues up the FDA to authorize the vaccine. Next week, the CDC will consider its own authorization. Once signed off by the CDC, the Pfizer vaccine can be administered in children immediately. Dr. Christina Johns, Senior Medical Advisor at PM Pediatrics, joined Cheddar's Search for a Cure.
Dr. Vivek Cherin, Internal Medicine Physician at Amita Health, joined Cheddar's Search for a Cure to break down what we need to know about eligibility and availability of COVID-19 vaccine boosters.
World leaders will converge this weekend at the 2021 G20 Summit in Rome and the UN COP26 conference in Glasgow with the climate crisis on the agenda. Lord Adair Turner, chair of the Energy Transitions Commission, joined Cheddar to discuss what people can expect to come out of the climate-focused conferences. Turner also noted that one of the biggest hurdles for the attending nations will be coming to a uniform decision on expanding on the Paris Climate Accord goals that have become insufficient to prevent global warming by 1.5 degrees celsius.
Nicole Lambert, President at Myriad Genetics joins ChedHER to discuss how to expand access to genetic testing for all women, and how her experience as a 'pre-vivor' motivates her role in the industry.
Carlo and Baker cover Facebook's big rebrand, the latest on Biden's economic agenda and more. Plus, ranking the best Halloween candy and the worst couple's costumes.
Proptech startup Juno recently raised $20 million in a Series A funding round. The company says the funds will be used to further its mission of building sustainable and affordable apartment buildings across the United States. Juno Co-Founder and CEO Jonathan Sherr joined Cheddar News' Closing Bell to discuss.
Stacey Stevens, President of iCAD, joins 'Cheddar Innovates' to discuss how 'Profound A.I. Risk' works as a short-term breast cancer risk estimation for women.
On this episode of 'Cheddar Innovates': President of iCAD breaks down how its technology is being used as a short-term breast cancer risk estimation for women; A look at Curiosity Stream's 'The Science of Thrills.'
Pharmaceutical company Merck has announced that it will share the formula of its COVID-19 pill with poor countries free of charge. The company still intends to charge wealthier nations leaving the end cost at more than $700 per five-day treatment course.
Dems race for a deal on President Biden's economic agenda ahead of his big foreign trip. What to make of the latest threat assessment in Afghanistan. Plus, the meme cryptocurrency of the moment that's now worth more than many Fortune 500 companies.
